Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India flag India · Delayed Price · Currency is INR
1,566.00
-45.30 (-2.81%)
Last updated: Nov 16, 2026, 3:29 PM IST

Symbiotec Pharmalab Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
217.66100.4263.974.9545.5191.62
Short-Term Investments
-0.850.790.688.733.79
Cash & Short-Term Investments
217.66101.25264.6975.6354.2495.41
Cash Growth
--61.75%249.98%39.44%-43.15%-
Accounts Receivable
2,6832,0011,7571,2571,1201,435
Other Receivables
-114.64158.59140.16139.8458.04
Receivables
2,6832,1161,9151,3971,2591,493
Inventory
3,0342,3692,6153,3582,4382,457
Prepaid Expenses
-52.9250.7450.9544.5957.26
Other Current Assets
587.91216.8483.49200.76205.74152.27
Total Current Assets
6,5224,8554,9295,0824,0024,255
Property, Plant & Equipment
11,93111,4899,6976,1954,8073,184
Long-Term Investments
44.8444.8414.535.1148.1954.05
Other Intangible Assets
---2.387.512.62
Other Long-Term Assets
1,8311,4191,1561,6331,036646.3
Total Assets
20,43917,80815,79712,9489,9008,152

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1,7271,383884.962,276879.7887.73
Accrued Expenses
67.25196.22147.1129.51124.43167.7
Short-Term Debt
-2,8752,284502.971,053635.88
Current Portion of Long-Term Debt
1,709319.99595.0416.6663.36
Current Portion of Leases
5.3210.258.775.47--
Current Income Taxes Payable
136.3479.46110.0830.494.8820.34
Current Unearned Revenue
-135.05358.15417.2171.153.96
Other Current Liabilities
1,153276.39337.8133.68141.84118.01
Total Current Liabilities
4,7985,2764,7263,5122,2811,887
Long-Term Debt
1,622684.132,5301,9521,1207.31
Long-Term Leases
22.3420.5126.4228.4420.7811.32
Long-Term Unearned Revenue
-39.58----
Pension & Post-Retirement Benefits
-168.839477.360.9255.76
Long-Term Deferred Tax Liabilities
-58.13219.91199.44201.58204.47
Other Long-Term Liabilities
388.4865.1953.0429.721.47-
Total Liabilities
6,8316,3127,6495,7993,6852,166

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
128.51125.47109.36109.36109.36109.36
Additional Paid-In Capital
-3,9101,6111,6111,6111,611
Retained Earnings
-7,5426,4465,4844,4954,266
Comprehensive Income & Other
13,481-80.82-17.76-54.22--
Total Common Equity
13,60911,4978,1497,1506,2155,987
Minority Interest
-1.33-1.4-1.89-2.05-0.92-1.09
Shareholders' Equity
13,60811,4968,1477,1486,2145,986
Total Liabilities & Equity
20,43917,80815,79712,9489,9008,152

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
3,3593,9105,4442,5062,200657.87
Net Cash (Debt)
-3,141-3,809-5,180-2,430-2,145-562.46
Net Cash Growth
------
Net Cash Per Share
-51.23-65.86-92.89-43.66-39.23-10.29
Filing Date Shares Outstanding
63.0862.7354.6855.6654.6854.68
Total Common Shares Outstanding
63.0862.7354.6855.6654.6854.68
Working Capital
1,724-420.21202.61,5701,7212,368
Book Value Per Share
215.75183.27149.02128.46113.66109.49
Tangible Book Value
13,60911,4978,1497,1486,2085,974
Tangible Book Value Per Share
215.75183.27149.02128.42113.53109.26
Land
-103.55102.01101.01101.01101.01
Buildings
-2,8091,3081,268979.51924.58
Machinery
-10,4344,6054,3313,1312,915
Construction In Progress
-644.815,6822,0831,821396.79